high-grade serous ovarian cancer

February 9, 2021February 9, 2021

€15M EU Project Seeks to Improve Personalized Medicine Options

News

The European Union is providing nearly €15 million ($18.1 million) over five years to improve personalized medicine options for people with drug-resistant high-grade serous ovarian cancer. The DECIDER project, funded ... Read more

May 13, 2019May 13, 2019

ctDNA Sampling May Help Tailor Treatment for Difficult-to-Treat Ovarian Cancer, Study Suggests

News

An analysis of circulating tumor DNA, or ctDNA, can help guide treatment decisions for patients with difficult-to-treat high-grade serous ovarian cancer, a study shows. The study, “Prospective Longitudinal ctDNA Workflow ... Read more

December 14, 2018

Stanford Pursues New Research to Understand Spread and Resistance of Aggressive Ovarian Cancer

News

A team led by researchers at Stanford University will test an approach combining new materials and imaging technologies to provide a deeper understanding of how high-grade serous ovarian cancer develops. The condition is ... Read more

October 29, 2018October 29, 2018

Cancer Cells from Fallopian Tube Communicate with Healthy Ovaries to Promote Cancer Growth, Researchers Find

News

Cancer cells from the fallopian tube — the precursors of ovarian cancer — communicate with healthy ovaries and trigger the release of a hormone called norepinephrine, creating an environment for ... Read more

October 10, 2018

CT45 Protein Predicts Longer Survival Times in Advanced-stage Ovarian Cancer, Study Reports

News

A protein called CT45 predicts which ovarian cancer patients will respond to platinum-based chemotherapy and is associated with extended survival in these patients, being a new prognostic marker for ovarian ... Read more

September 10, 2018

Ovarian Cancer Cells Retain Iron to Fuel Growth, Research Suggests

News

Iron accumulation, a well-known feature of ovarian cancer cells, may play a role in cancer progression by increasing fatty acid metabolism, researchers at UConn Health suggest. Their study, “A Systems Biology Approach to ... Read more

May 11, 2018

Lynparza Tablets Approved in EU to Treat Advanced, Platinum-sensitive Ovarian Cancers

News

The European Medicines Agency (EMA) has approved Lynparza (olaparib) tablets as a maintenance therapy for ovarian cancer patient who have relapsed, but have had a complete or partial response to platinum-based chemotherapy, and ... Read more

July 18, 2016July 18, 2016

Immunotherapy Following Chemotherapy May Benefit Metastatic Ovarian Cancer Patients

News

Women with metastatic ovarian cancer treated with chemotherapy prior to surgery have higher levels of specific immune cells with the ability to attack tumor cells. These findings suggest that immunotherapy designed to remove the breaks ... Read more